A carregar...
DIABRISK-SL trial: further consideration of age and impact of imputations
Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality worldwide. Early interventions may help to delay or prevent onset of cardiometabolic endpoints of clinical importance to T2DM patients. Wijesuriya et al. (BMC Med 15:146, 2017) published results of a randomised controlled tr...
Na minha lista:
| Publicado no: | BMC Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6598268/ https://ncbi.nlm.nih.gov/pubmed/31248404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1361-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|